Interventional Procedure Segment, by Surgical Procedure Account Largest Share in Pediatric Cardiology Market during 2024-2031

According to our new research study on "Pediatric Cardiology Market Forecast to 2031 - Global Analysis - by Product Type, Modality, End User, and Geography," the market was valued at US$ 6,634.00 million in 2024 and is projected to reach US$ 10,389.77 million by 2031; it is expected to register a CAGR of 6.6% during 2024-2031. The pediatric cardiology market growth is attributed to the increasing incidence of congenital heart disease in pediatrics and the growing shift toward minimally invasive procedures.

Increasing Incidence of Congenital Heart Disease in Pediatrics

Chronic congenital heart disease (CCHD), tetralogy of fallot, ventricular septal defect, and atrial septal defect are a few congenital heart diseases (CHDs) that are present from birth. The rising prevalence of maternal health issues, such as diabetes and obesity, has been linked to an increased risk of CHD in newborns. According to the Children's Heart Foundation, CHD is the most common congenital disability in the US. As per the same source, approximately one of every 110 babies is born with a CHD, and each year, ~40,000 babies are born with CHD in the US. In 2023, approximately 20 of every 10,000 babies born in the US were suffering from CCHD, as per the American Academy of Pediatrics. According to the Centers for Disease Control and Prevention (CDC), about 1 in 2,077 babies, that is ~1,768 babies every year in the US, are born with tetralogy of fallot. Furthermore, 13 of every 10,000 babies, about 5,240 babies, in the US each year suffer from atrial septal defects at birth. In addition, about 42 of every 10,000 babies, or ~16,800 babies in the US, are born with ventricular septal defects each year. According to the Children's Heartlink organization 2024 report, ~1.3 million children are born with CHD globally every year. As per As survival rates for infants with CHD improve due to advancements in medical care, there is a growing population of children and adolescents requiring ongoing cardiology services. This shift has resulted in a heightened demand for specialized pediatric cardiac care, including diagnostic, surgical, and therapeutic interventions. Thus, the increasing incidence of various congenital heart diseases (CHDs) in the pediatric population fuels the growth of the global pediatric cardiology markets.

Based on product type, the pediatric cardiology market is categorized into transcatheter heart valves, occlusion devices, catheters, stents, introducer sheaths, and others. In 2024, the transcatheter heart valves segment held a significant pediatric cardiology market share. Transcatheter heart valve is an alternative to open heart surgery for kids who have a failing, surgically placed heart valve. The transcatheter heart valve might not replace open-heart surgery as a treatment option, but it can help delay surgery and improve quality of life. Various pediatric hospitals are focusing on providing programs for opting for less invasive treatments; e.g., using transcatheter valves rather than open surgery to treat congenital heart defects. Children's Hospital Los Angeles provides heart valve programs that support the use of new techniques and treatments to offer the best possible quality of life to children. The program offers excellent outcomes, world-renowned experts, and child-focused care. Similarly, the Heart Institute at Children's Hospital Colorado uses minimally invasive cardiac catheters to treat heart problems in kids. The institute's Transcatheter Pulmonary Valve Program is a significant alternative to open-heart surgery that can improve life for children suffering from several types of congenital heart defects.

Based on disease indication, the market is segmented into congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. The congenital heart disease segment held the largest pediatric cardiology market share in 2024, and the same segment is estimated to register the higher CAGR during 2024-2031. The congenital heart disease (CHD) segment in the global pediatric cardiology market is a critical area of focus, as it encompasses a wide range of structural heart defects present at birth. According to Children's Heart Foundation, CHD is the most common congenital disability in the US. Nearly one of every 110 babies is born with a CHD, and each year, approximately 40,000 babies are born in the country. Major institutions that are at the forefront of providing such comprehensive care to these patients include Boston Children's Hospital and Mayo Clinic, offering specialized surgical and interventional options. It has dramatically changed the treatment paradigms in the form of minimally invasive procedures, including catheter-based interventions, such as ASD closure and transcatheter pulmonary valve replacement, with lower recovery times and complications. Research on genetics and new treatments to better understand and manage CHD is also growing. Long-term care strategies are also on the rise as patients survive into adulthood, which results in more extended care. During the forecast period, the congenital heart disease segment is expected to grow significantly with growing innovations in treatment, improving outcomes for patients, and increasing awareness about the need for specialized pediatric cardiology.

Based on surgical procedure, the market is segmented into interventional procedures, heart rhythm management procedures, and others. The interventional procedures segment held the largest pediatric cardiology market share in 2024, and the same segment is estimated to register the higher CAGR during 2024-2031. The interventional procedures segment is likely to grow strongly owing to the development of minimally invasive techniques and an increasing awareness of congenital heart defects in children. A catheter-based intervention for ASD, coarctation of the aorta, and pulmonary valve stenosis, among other conditions, is highly effective and does not require open-heart surgery. Shorter recovery times and less hospitalization are observed with the use of Amplatzer Septal Occluder and balloon dilation catheters. Pediatric cardiology teams are emphasizing training programs and collaborations from multidisciplinary teams to remain updated with the most recent techniques. Interventional procedures significantly improve the quality of care and long-term health outcomes of children suffering from cardiovascular conditions.

Based on end user, the market is segmented into hospitals, specialty clinics, others. The hospital segment held the largest pediatric cardiology market share in 2024, and the same segment is estimated to register the highest CAGR during 2024-2031. In pediatric cardiology market, the hospitals segment is significant in terms of delivering specialized care to children suffering from cardiovascular disorders. The increasing cases of congenital heart defects and other heart diseases have elevated pediatric cardiac centers with modern technologies and multidisciplinary teams for comprehensive treatment. Boston Children's Hospital, Texas Children's Hospital, Seattle Children's Hospital, and the Children's Hospital of Philadelphia are among the acknowledged leaders, boasting state-of-the-art facilities and innovative approaches to pediatric cardiology-including minimally invasive surgical techniques and interventional procedures. These hospitals emphasize collaborative care, where a cardiologist works with other surgeons, anesthesiologists, and nursing staff to ensure optimized treatment results. Seattle Children's Hospital performed ~570 pediatric heart surgeries in 2023. Recent investments in telemedicine and remote monitoring technologies further enhance patient management, with constant care and follow-up, highly necessary for patients located in rural areas. Access to specialized care and treatment protocols enhanced in health systems ensures growth in the hospitals segment and advancements in pediatric cardiology, which will improve the quality of life for young patients suffering from cardiovascular problems.

Koninklijke Philips NV, ResMed Inc, BLS Systems Limited, Besmed Health Business Corp, Flexicare (Group) Limited, Sleepnet Corporation, Circadiance, Dynarex Corp, Intersurgical LtdArmstrong Medical Ltd, Ambu AS, SunMed Group Holdings LLC (AirLife), Dragerwerk AG & Co KGaA, and Fisher & Paykel Healthcare Corp Ltd. are among the leading companies operating in the global pediatric cardiology market.

Companies operating in the pediatric cardiology market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the pediatric cardiology market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall pediatric cardiology market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

?

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused on market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, type, end users, etc., which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or would like further information, please contact us:

? North America: +1 646 491 9876

? Asia Pacific: +91 20 6727 8686

? Email: sales@theinsightpartners.com

Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the publisher,